Our People

Board of Directors

Affiliate Members

The NYGC provides Affiliate Memberships to external academic researchers who have a significant interest in and commitment to the scientific life and work of the NYGC, and will contribute to and benefit from the NYGC’s mission.

Researchers who hold primary academic and/or clinical appointments at Institutional Founding Member and Institutional Associate Member organizations are eligible to be considered for an appointment as Affiliate Members.

The NYGC currently has 95 Affiliate Members, hailing from 18 academic institutions and medical centers. Please email Affiliate affiliate@nygenome.org if you are interested in applying to the program.

NYGC Affiliate Members

Cory Abate-Shen, PhD,
Columbia University
Schahram Akbarian, MD, PhD,
Icahn School of Medicine at Mount Sinai
Christopher Barbieri, MD, PhD,
Weill Cornell Medicine
Michael Berger, PhD,
Memorial Sloan Kettering Cancer Center
Richard Bonneau, PhD,
New York University
Kristen Brennand, PhD,
Icahn School of Medicine at Mount Sinai
Harmen J. Bussemaker, PhD,
Columbia University
Joseph Buxbaum, PhD,
Icahn School of Medicine at Mount Sinai
Andrea Califano, PhD,
Columbia University
Lewis Cantley, PhD,
Weill Cornell Medicine
Aravinda Chakravarti, PhD,
New York University
Alexander Charney, MD, PhD,
Icahn School of Medicine at Mount Sinai
Wendy Chung, MD, PhD,
Columbia University
Dalton Conley, PhD,
Princeton University
Isidro Cortes Ciriano, PhD,
European Bioinformatics Institute
Christopher Cunniff, MD,
Weill Cornell Medicine
Philip De Jager, MD, PhD,
Columbia University
Olivier Elemento, PhD,
Weill Cornell Medicine
Eleazar Eskin, PhD,
UCLA
Bishoy Morris Faltas, MD,
Weill Cornell Medicine
Howard A. Fine, MD,
Weill Cornell Medicine
Erin Flaherty, PhD,
Columbia University
Fieke Froeling, MD, PhD,
Cold Spring Harbor Laboratory
Kevin Gardner, MD, PhD,
Columbia University
Jellert Gaublomme, PhD,
Columbia University
Thomas R. Gingeras, PhD,
Cold Spring Harbor Laboratory
Alison Goate, DPhil,
Icahn School of Medicine at Mount Sinai
John Greally, MD, PhD,
Albert Einstein College of Medicine
Benjamin Greenbaum, PhD,
Icahn School of Medicine at Mount Sinai
Steven S. Gross, PhD,
Weill Cornell Medicine
Cheryl Y. Hayashi, PhD,
American Museum of Natural History
Liam Holt, PhD,
New York University
George Hripcsak, MD,
Columbia University
Benjamin Izar, MD, PhD,
Columbia University
Simon John, PhD,
The Jackson Laboratory
Marko Jovanovic, PhD,
Columbia University
Eimear Kenny, PhD,
Icahn School of Medicine at Mount Sinai
Ekta Khurana, PhD,
Weill Cornell Medicine
Jennie Kline, PhD,
Columbia University
Andrew Kung, MD, PhD,
Memorial Sloan Kettering Cancer Center
Steven Kushner, MD, PhD,
Columbia University
Marc Ladanyi, MD,
Memorial Sloan Kettering Cancer Center
Gina Lee, PhD,
Weill Cornell Medicine
Todd Lencz, PhD,
Northwell Health/Feinstein Institute for Medical Research
Ross Levine, MD,
Memorial Sloan Kettering Cancer Center
Steven Lipkin, MD, PhD,
Weill Cornell Medicine
Massimo Loda, MD,
Weill Cornell Medicine
David Lyden, MD, PhD,
Weill Cornell Medicine
Luciano Martelotto, PhD,
Harvard University
Christopher Mason, PhD,
Weill Cornell Medicine
W. Richard McCombie, PhD,
Cold Spring Harbor Laboratory
Ari Melnick, MD,
Weill Cornell Medicine
Vilas Menon, PhD,
Columbia University
JJ Miranda, PhD,
Barnard College
Bud Mishra, PhD,
New York University
Juan Miguel Mosquera, MD, MSc,
Weill Cornell Medicine
Parvathi A. Myer, MD,
Albert Einstein College of Medicine
Benjamin G. Neel, MD, PhD,
New York University
Kenneth Offit, MD,
Memorial Sloan Ketting Cancer Center
William Oh, MD,
Icahn School of Medicine at Mount Sinai
Ramon Parsons, MD, PhD,
Icahn School of Medicine at Mount Sinai
Chiraag D. Patel, MD,
Stony Brook University
Paz Polak, PhD,
Icahn School of Medicine at Mount Sinai
Scott Powers, PhD,
Stony Brook University
Molly Przeworski, PhD,
Columbia University
Raul Rabadan, PhD,
Columbia University
Ben Raphael, PhD,
Princeton University
Ed Reznik, PhD,
Memorial Sloan Kettering Cancer Center
Jeffrey Rosenfeld, PhD,
Rutgers
M. Elizabeth Ross, MD, PhD,
Weill Cornell Medicine
Kevin A Roth, MD, PhD,
Columbia University
Panos Roussos, MD, PhD,
Icahn School of Medicine at Mount Sinai
Anil Rustgi, MD,
Columbia University
Charles Sawyers, MD,
Memorial Sloan Kettering Cancer Center
Nikolaus Schultz, PhD,
Memorial Sloan Kettering Cancer Center
Sohrab P. Shah, PhD,
Memorial Sloan Kettering Cancer Center
Wen H. Shen, PhD,
Weill Cornell Medicine
Yufeng Shen, PhD,
Columbia University
Kosaku Shinoda, PhD,
Albert Einstein College of Medicine
Adam Siepel, PhD,
Cold Spring Harbor Laboratory
Jane Skok, PhD,
New York University
Barry Sleckman, MD, PhD,
Weill Cornell Medicine
Matija Snuderl, MD,
New York University
Sohail Tavazoie, MD, PhD,
The Rockefeller University
Alison Taylor, PhD,
Columbia University
Barry S. Taylor, PhD,
Memorial Sloan Kettering Cancer Center
David Tuveson, MD, PhD,
Cold Spring Harbor Laboratory
Krishna Veeramah, PhD,
Stony Brook University
Thomas Vierbuchen, PhD,
Memorial Sloan Kettering Cancer Center
Julia Wattacheril, MD,
Columbia University
George Weinstock, PhD,
The Jackson Laboratory
Hynek Wichterle, PhD,
Columbia University
Youzhi Xu, PhD
Memorial Sloan Kettering Cancer Center
Itai Yanai, PhD,
New York University
Chaolin Zhang, PhD,
Columbia University

Scientific Working Groups

The NYGC has established scientific working groups with the objective of bringing together NYGC researchers and the scientific community to advance disease-based research in areas where our strengths and experience can make a significant difference.

  • Neurodegenerative Disease Working Group, led by Alison Goate, DPhil, Icahn School of Medicine at Mount Sinai, Hemali Phatnani, PhD, NYGC, and Phil De Jager, PhD, MD, MMSc, Columbia University Irving Medical Center.
  • Neuropsychiatric Disease Working Group, led by NYGC Scientific Director of Neuropsychiatric Disease Genomics Thomas Lehner, PhD, MPH
  • Computational Cancer Genomics Working Group, led by Simon Tavaré, PhD, NYGC and Columbia University, and Sohrab Shah, PhD, Memorial Sloan Kettering Cancer Center.
  • Enabling Innovation Working Group, led by NYGC Senior Scientific Director of Cancer Genomics Samuel Aparicio, PhD
  • Population Genomics Working Group, led by Adam Siepel, PhD, Cold Spring Harbor Laboratory, and Eimear Kenny, PhD, Icahn School of Medicine at Mount Sinai.
  • Genome Center Cancer Group, led by Harold Varmus, MD, NYGC and Weill Cornell, and Charles Sawyers, MD, Memorial Sloan Kettering Cancer Center.
Scientist working on an experiment in a lab